Request Sample Inquiry
Theranostics Market

Theranostics Market

Theranostics Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

196

Base Year:

2023

Date

Apr - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2451

Segments Covered
  • By Products By Products Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software & Services
  • By Application By Application Prostate Cancer, Bone Metastasis, Other Applications
  • By End User By End User Hospitals & Cancer Care Centers, Theranostics Centers, Research & Academic Centers
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 2091 Million
Revenue 2032Revenue 2032: USD 6805.1 Million
Revenue CAGRRevenue CAGR (2024 - 2032): 14%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Theranostics Market - Segment Analysis
    1. Overview
    2. Global Theranostics Market, 2016 - 2028 (USD Million)
    3. Global Theranostics Market - by Products
      1. By Diagnostic Imaging
      2. By Radiopharmaceuticals
      3. By IVD/Biomarker Screening
      4. By Software & Services
    4. Global Theranostics Market - by Application
      1. By Prostate Cancer
      2. By Bone Metastasis
      3. By Other Applications
    5. Global Theranostics Market - by End User
      1. By Hospitals & Cancer Care Centers
      2. By Theranostics Centers
      3. By Research & Academic Centers
    6. Global Theranostics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Theranostics Market - Segment Analysis
    1. Overview
    2. North America Theranostics Market, 2016 - 2028 (USD Million)
    3. North America Theranostics Market, by Products
      1. By Diagnostic Imaging
      2. By Radiopharmaceuticals
      3. By IVD/Biomarker Screening
      4. By Software & Services
    4. North America Theranostics Market, by Application
      1. By Prostate Cancer
      2. By Bone Metastasis
      3. By Other Applications
    5. North America Theranostics Market, by End User
      1. By Hospitals & Cancer Care Centers
      2. By Theranostics Centers
      3. By Research & Academic Centers
    6. North America Theranostics Market, by Country
      1. U.S.
        1. U.S. Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. U.S. Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. U.S. Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      2. Canada
        1. Canada Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Canada Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Canada Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      3. Mexico
        1. Mexico Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Mexico Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Mexico Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
  5. Europe Theranostics Market - Segment Analysis
    1. Overview
    2. Europe Theranostics Market, 2016 - 2028 (USD Million)
    3. Europe Theranostics Market, by Products
      1. By Diagnostic Imaging
      2. By Radiopharmaceuticals
      3. By IVD/Biomarker Screening
      4. By Software & Services
    4. Europe Theranostics Market, by Application
      1. By Prostate Cancer
      2. By Bone Metastasis
      3. By Other Applications
    5. Europe Theranostics Market, by End User
      1. By Hospitals & Cancer Care Centers
      2. By Theranostics Centers
      3. By Research & Academic Centers
    6. Europe Theranostics Market, by Country
      1. Germany
        1. Germany Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Germany Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Germany Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      2. UK
        1. UK Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. UK Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. UK Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      3. France
        1. France Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. France Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. France Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      4. Spain
        1. Spain Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Spain Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Spain Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      5. Italy
        1. Italy Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Italy Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Italy Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      6. BENELUX
        1. BENELUX Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. BENELUX Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. BENELUX Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      7. Rest of Europe
        1. Rest Of Europe Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Rest Of Europe Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Rest Of Europe Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
  6. Asia Pacific Theranostics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Theranostics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Theranostics Market, by Products
      1. By Diagnostic Imaging
      2. By Radiopharmaceuticals
      3. By IVD/Biomarker Screening
      4. By Software & Services
    4. Asia Pacific Theranostics Market, by Application
      1. By Prostate Cancer
      2. By Bone Metastasis
      3. By Other Applications
    5. Asia Pacific Theranostics Market, by End User
      1. By Hospitals & Cancer Care Centers
      2. By Theranostics Centers
      3. By Research & Academic Centers
    6. Asia Pacific Theranostics Market, by Country
      1. China
        1. China Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. China Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. China Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      2. Japan
        1. Japan Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Japan Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Japan Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      3. India
        1. India Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. India Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. India Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      4. South Korea
        1. South Korea Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. South Korea Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. South Korea Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      5. South East Asia
        1. South East Asia Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. South East Asia Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. South East Asia Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Rest of Asia Pacific Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Rest of Asia Pacific Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
  7. Latin America Theranostics Market - Segment Analysis
    1. Overview
    2. Latin America Theranostics Market, 2016 - 2028 (USD Million)
    3. Latin America Theranostics Market, by Products
      1. By Diagnostic Imaging
      2. By Radiopharmaceuticals
      3. By IVD/Biomarker Screening
      4. By Software & Services
    4. Latin America Theranostics Market, by Application
      1. By Prostate Cancer
      2. By Bone Metastasis
      3. By Other Applications
    5. Latin America Theranostics Market, by End User
      1. By Hospitals & Cancer Care Centers
      2. By Theranostics Centers
      3. By Research & Academic Centers
    6. Latin America Theranostics Market, by Country
      1. Brazil
        1. Brazil Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Brazil Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Brazil Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      2. Argentina
        1. Argentina Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Argentina Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Argentina Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      3. Rest of Latin America
        1. Rest of Latin America Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Rest of Latin America Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Rest of Latin America Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
  8. Middle East & Africa Theranostics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Theranostics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Theranostics Market, by Products
      1. By Diagnostic Imaging
      2. By Radiopharmaceuticals
      3. By IVD/Biomarker Screening
      4. By Software & Services
    4. Middle East & Africa Theranostics Market, by Application
      1. By Prostate Cancer
      2. By Bone Metastasis
      3. By Other Applications
    5. Middle East & Africa Theranostics Market, by End User
      1. By Hospitals & Cancer Care Centers
      2. By Theranostics Centers
      3. By Research & Academic Centers
    6. Middle East & Africa Theranostics Market, by Country
      1. GCC Countries
        1. GCC Countries Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. GCC Countries Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. GCC Countries Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      2. South Africa
        1. South Africa Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. South Africa Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. South Africa Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Theranostics Market, By Products
          1. By Diagnostic Imaging
          2. By Radiopharmaceuticals
          3. By IVD/Biomarker Screening
          4. By Software & Services
        2. Rest of Middle East & Africa Theranostics Market, By Application
          1. By Prostate Cancer
          2. By Bone Metastasis
          3. By Other Applications
        3. Rest of Middle East & Africa Theranostics Market, By End User
          1. By Hospitals & Cancer Care Centers
          2. By Theranostics Centers
          3. By Research & Academic Centers
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. GE Healthcare Technologies (U.S.)
    2. BAMF Health (U.S.)
    3. Siemens Healthcare AG (Germany)
    4. Canon Medical Systems Corporation (Japan)
    5. Curasight (Denmark)
    6. Cardinal Health Inc. (U.S.)
    7. Radiopharm Theranotics Ltd. (Australia)
    8. Clarity Pharmaceuticals Ltd. (Australia)
    9. Point Biopharma Global Inc. (U.S.)
    10. Nuview Life Sciences (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 09-Apr-2024
Advancing Theranostics: Accelerated Clinical Pipeline Targets Critical Cancer Indications
FAQ
Frequently Asked Question

  • The global Theranostics valued at USD 2091 Million in 2023 and is expected to reach USD 6805.1 Million in 2032 growing at a CAGR of 14%.

  • The prominent players in the market are GE Healthcare Technologies (U.S.), BAMF Health (U.S.), Siemens Healthcare AG (Germany), Canon Medical Systems Corporation (Japan), Curasight (Denmark), Cardinal Health Inc. (U.S.), Radiopharm Theranotics Ltd. (Australia), Clarity Pharmaceuticals Ltd. (Australia), Point Biopharma Global Inc. (U.S.), Nuview Life Sciences (U.S.),.

  • The market is project to grow at a CAGR of 14% between 2024 and 2032.

  • The driving factors of the Theranostics include

    • Increasing Demand for Personalized Medicine due to the understanding that individuals respond uniquely to treatments based on their genetic makeup, disease characteristics, and lifestyle factors

  • North America was the leading regional segment of the Theranostics in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy